Massachusetts Board of Pharmacy to Take a Big Step: Licensing Nonresident Pharmacies - Holland & Knight
Massachusetts Board of Pharmacy will begin licensing nonresident pharmacies, requiring out-of-state pharmacies that ship into MA to obtain a license and comply with state regulations.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Nonresident pharmacies (including independent, retail chain, compounding, and long-term-care pharmacies) that dispense and ship controlled substances or other prescription drugs into Massachusetts. should confirm how it applies to their specific situation before acting. There is a time constraint attached: The licensing requirement is effective upon the Board's final rulemaking; pharmacies should apply immediately to avoid disruption.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Previously, nonresident pharmacies were not required to hold a Massachusetts pharmacy license. Now they must obtain a license from the MA Board of Pharmacy and comply with all state laws, including those for controlled substances.
Who it affects
Nonresident pharmacies (including independent, retail chain, compounding, and long-term-care pharmacies) that dispense and ship controlled substances or other prescription drugs into Massachusetts.
What you must do
Apply for a nonresident pharmacy license with the Massachusetts Board of Pharmacy and ensure compliance with MA pharmacy laws, including PDMP reporting, e-prescribing, and controlled substance regulations.
Deadline
The licensing requirement is effective upon the Board's final rulemaking; pharmacies should apply immediately to avoid disruption.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- IL HB0004: MEDICAID-PHARMACY SERVICES
- Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661
- Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
- Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability
- Amanda Ward, N.D.; Decision and Order